Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT 201 (Bocouture) vs placebo for moderate to severe platysma prominence
2025-520499-24-00Phase 3Authorised
- Sponsor
- Merz
- Start
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in Platysmal Bands comparing NT 201 (Bocouture) with Placebo (2 arms). Primary endpoint: Primary composite aesthetic response at Week 2. Planned start Oct 2025; status: authorised.
02
Drugs
botulinum toxin type A
03
Conditions
Platysmal Bands
Beyond the preview
Go deeper on 2025-520499-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520499-24-00.